Abbott | Actif À Court Terme



Current Assets Changement Date
Abbott USD 23.15B 503M 2025-03
Agilent USD 4.21B 101M 2025-04
AtriCure USD 251.48M 16.34M 2025-03
Baxter International USD 8.85B 11M 2024-12
Becton, Dickinson and Co. USD 8.67B 7M 2025-03
Bio-Rad Laboratories USD 3.04B 6.3M 2025-03
Boston Scientific USD 7.34B 415M 2025-03
Cooper Companies USD 1.99B 35.5M 2025-01
Danaher USD 9.52B 28M 2025-03
Dexcom USD 4.55B 252.4M 2025-03
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Globus Medical USD 1.71B 467.15M 2025-03
Hologic USD 3.21B 284.9M 2025-03
Insulet USD 2.33B 437.1M 2025-03
Integra LifeSciences USD 1.11B 25.57M 2025-03
Intuitive Surgical USD 11.88B 331.3M 2025-03
J&J USD 71.55B 15.66B 2025-03
Masimo USD 1.18B 41.8M 2025-03
Medtronic USD 23.81B 1.3B 2025-04
Merit Medical Systems USD 958.64M 34.86M 2025-03
Pfizer USD 45.86B 4.5B 2025-03
Smith & Nephew USD 4.42B 37M 2024-12
Solventum Corp 3.05B 196M 2025-03
Stryker USD 13.02B 1.83B 2025-03
Tandem Diabetes Care USD 663.44M 61.06M 2025-03
Teleflex USD 1.54B 67.79M 2025-03
Terumo JPY 723.5B 12.47B 2025-03
Thermo Fisher Scientific USD 23.38B 1.24B 2025-03
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12



Abbott Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.